Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma

BACKGROUND: As HER2 is expressed in 30% of oesophageal squamous cell carcinomas (ESCCs), T-cell-based immunotherapy and monoclonal antibodies targeted against HER2 are attractive, novel approaches for ESCCs. However, it was shown that there is an inverse correlation between HER2 and MHC class I expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, T, Mimura, K, Sato, E, Watanabe, M, Mizukami, Y, Kawaguchi, Y, Ando, T, Kinouchi, H, Fujii, H, Kono, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939777/
https://www.ncbi.nlm.nih.gov/pubmed/20628381
http://dx.doi.org/10.1038/sj.bjc.6605772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939777/
https://www.ncbi.nlm.nih.gov/pubmed/20628381
http://dx.doi.org/10.1038/sj.bjc.6605772

Ejemplares similares